FDA-Inspected Site

Intercos Europe SpA

2 FDA inspections are on record for Intercos Europe SpA in Agrate Brianza, Italy.

483· Form 483 issued

Agrate Brianza, Italy · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-03-15.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Mar 2024 – 15 Mar 2024Human DrugsWLView 483 →
9 Feb 2015 – 13 Feb 2015Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

15 Mar 2024
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Joseph A Piechocki

15 Mar 2024
21 CFR 211.194(a)

Complete test data included in records

Cited by Joseph A Piechocki

15 Mar 2024
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Joseph A Piechocki

15 Mar 2024
21 CFR 211.84(b)

Representative Samples Criteria

Cited by Joseph A Piechocki

15 Mar 2024
21 CFR 211.84(d)(2)

Reports of Analysis (Components)

Cited by Joseph A Piechocki

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Intercos Europe SpA's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat